capillary bed, extravasation, proliferation of a metastatic focus, and defense against host immune responses. 2 EMT is an important step in the initial transformation of metastatic cancer. 3 It includes morphological changes of the tumor cell, decreased intercellular adhesion, increased cell motility, and other processes. 4 An increasing number of studies have shown that abnormal activation of EMT promotes the progression of malignant tumors. [5] [6] [7] Previous studies have also shown that Wnt/b-catenin signaling plays an important role in the development and promotion of EMT and cancer metastasis. 8 Cancer stem cells, also known as tumor-initiating cells, are a subset of tumor cells with the capacity for self-renewal and unlimited proliferation. Many studies have shown the relationship between CSC and tumorigenesis and subsequent tumor development; in addition, the ability of CSC to migrate makes metastasis possible. 9, 10 Therefore, CSC play an important role in tumor survival, proliferation, metastasis, and recurrence.
A previous study on head and neck squamous cell carcinoma found that increased expression of miR-26b correlated with poor prognosis. 11 It has also been reported that miR-26b expression was upregulated in tissues and serum upon exacerbation of inflammatory bowel disease-associated carcinogenesis. 12 However, studies have
shown that the expression of miR-26b in CRC tissue is lower than that in normal tissue, suggesting that miR-26b depletion may play a role in the tumorigenesis of CRC. 13 Therefore, the role of miR-26b
in CRC metastasis remains under debate.
Phosphatase and tensin homolog is a tumor suppressor gene that antagonizes PI3K/Akt signaling and is frequently silenced in numerous tumor types. 14, 15 By inhibiting PI3K/Akt signaling, PTEN can inhibit bcatenin activity, ultimately affecting EMT. 14 In addition, previous studies in prostate cancer showed that by inhibiting the PI3K/Akt pathway, PTEN also significantly inhibits the formation of CSC. 16 Wingless-type MMTV integration site family member 5A, a member of the non-canonical Wnt family, suppresses the motility and invasiveness of cancer cells by CK1a activation, increasing formation of the b-catenin/E-cadherin complex at the cell membrane and inhibiting the Wnt/b-catenin signaling pathway, ultimately affecting EMT. 17 WNT5A
plays an important role in inhibiting the formation of various cancer types, such as CRC, thyroid cancer, and acute lymphoblastic leukemia.
18-20
Here we report that a human miRNA, miR-26b, promotes EMT and CSC formation by suppressing the expression of PTEN and WNT5A, consequently promoting CRC metastasis.
| MATERIALS AND METHODS

| Cell culture
The CRC cell lines Caco2 and DLD1 were purchased from the Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences.
The human embryonic kidney cell line HEK293T was purchased from the ATCC. Cells were maintained in DMEM (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% FBS (Life Technologies), 100 U/mL penicillin and 100 lg/mL streptomycin (Pen Strep;
Life Technologies).
| Transient transfection
The miR-26b mimic, inhibitors, and corresponding control oligonucleotides were purchased from RiboBio (RiboBio Co., Ltd, Guangzhou, China) and were transfected into Caco2 and DLD1 cells cultured in 6-well plates using Lipofectamine 2000 (Life Technologies), according to the manufacturer's instructions.
| Plasmids and generation of stably engineered cell lines
The miR-26b expression plasmid was generated by cloning the genomic pre-miR-26b gene, with a 300-bp sequence on each flanking side, into the lentiviral transfer plasmid pSin-puro (Takara Bio Inc., Kusatsu, Shiga, Japan) to generate pSin-miR-26b, which was cotransfected with psPAX and pMD2.G plasmids into HEK293T cells using standard calcium phosphate transfection as previously described. 21 Thirty-six hours after cotransfection, the supernatants were collected and incubated with cells to be infected for 24 hours in the presence of polybrene (2 lg/mL). After infection, puromycin (1.5 lg/mL) was used to select stably transduced cells over a 14-day period. PTEN and WNT5A coding sequences were generated by PCR amplification and cloned into the retroviral transfer plasmid pMSCV-puro (Clontech Laboratories Inc. 
GAPDH reverse, 5 0 -TGGGATTTCCATTGATGACAAG-3 0 .
| Western blot analysis
Western blots were carried out as described previously. 22 The following primary antibodies were used: anti-GAPDH, anti-PTEN, anti-WNT5A, and anti-N-cadherin (all from Abcam, Cambridge, UK; ab128915, ab32199, ab72583, and ab76011, respectively). IRDye 800CW goat anti-rabbit IgG and IRDye 680CW goat anti-mouse IgG (both from LI-COR Biosciences, Lincoln, NE, USA) were used as secondary antibodies. 
| Statistics
All statistical analyses were carried out using SPSS 19.0 statistical software. Continuous data were compared using Student's two-tailed t test. In all cases, P < .05 was considered statistically significant.
3 | RESULTS
| Expression of miR-26b is related to lymphatic metastasis of CRC
To investigate the relationship between miR-26b expression and CRC metastasis, we extracted CRC microRNA expression profiles from the Gene Expression Omnibus public microarray database (Series GSE29623). This analysis showed that in CRC patients, miR-26B expression was significantly higher in the presence of lymphatic metastasis (N1/N2 groups), than in its absence (N0 group; P = .01; Figure 1 ). This suggests that miR-26b expression may be associated with the development of CRC metastasis.
| Overexpression of miR-26b promotes the invasiveness and migration of CRC cells
To understand the biological effects of miR-26b on the metastasis of CRC cells, in vitro gain-of-function analyses were carried out using an overexpression strategy. Human CRC cell lines Caco2 and DLD1
with stable expression of miR-26b (Caco2-miR-26b and DLD1-miR26b) were generated, and upregulation of miR-26b in these cells was confirmed by RT-PCR, compared to cells transfected with corresponding control vectors (Caco2-and DLD1-vectors; Figure 2A ).
As shown in Figure 2B , overexpression of miR-26b in CRC cells led to a significant increase in the mesenchymal marker N-cadherin (Figure 2B ), suggesting that miR-26b might promote EMT. Consistent with this idea, Matrigel-coated (for invasion) and -uncoated (for migration)
Transwell assays showed that miR-26b overexpression significantly increased the invasion and migration of DLD1 cells ( Figure 2C,D) . Furthermore, wound-healing assays showed that miR-26b overexpression enhanced the migratory speed of DLD1 and Caco2 cells compared with control cells ( Figure 2E ). Collectively, these results suggest that miR-26b greatly contributes to the development of CRC metastasis.
| Overexpression of miR-26b promotes a stem cell-like phenotype in CRC cells
In addition to invasiveness and metastasis, we examined whether miR26b overexpression contributed to the promotion of a stem cell-like phenotype in CRC cells. We found that the mRNA expression levels in the pluripotency-and stem cell-associated markers LgR5, Bmi1, ALDH1, CD44, CD133, and CD166 were significantly increased in CRC cells after upregulation of miR-26b (P < .05; Figure 3A ).
In addition, we conducted a tumor sphere formation assay to examine the effect of miR-26b overexpression on the self-renewal of 
| Tumor suppressors PTEN and WNT5A are directly repressed by miR-26b
Using the bioinformatics tools TargetScan 23 and miRanda, 24 we confirmed that among the predicted targets, tumor suppressors PTEN and WNT5A had multiple highly conserved binding sites for miR-26b
( Figure 4A ). To determine whether miR-26b targets PTEN and WNT5A, we transfected miR-26b mimic and inhibitor into established CRC cell lines with high and low expression of miR-26b (Figure 4B ). WB analysis consistently showed decreased expression of PTEN and WNT5A in miR-26b-overexpressing cells, whereas miR26b inhibition increased the levels of these proteins ( Figure 4C ).
Similar trends were observed at the mRNA level ( Figure 4D ).
Furthermore, when luciferase was linked to the 3 0 UTR of PTEN or WNT5A, reporter assays showed decreased luciferase activity in miR26b mimic-transfected Caco2 and DLD1 cells compared with untransfected control cells ( Figure 4E ). Importantly, mutations introduced into the seed sequence of miR-26b ( Figure 4F ) abolished its suppressive effects ( Figure 4E ). Collectively, these data suggest that miR-26b directly suppresses PTEN and WNT5A expression in CRC cell lines. 
| DISCUSSION
Colorectal cancer is one of the most common malignant tumors, causing 700 000 deaths every year globally. 25 Benefitting from the rapid development of diagnostic techniques and treatments, the 5- year OS of patients with early-stage, non-lymph node metastatic CRC has reached 90%; however, the OS of patients with distant metastasis is only approximately 10%. 26 Therefore, in-depth study of the mechanisms behind CRC metastasis is crucial to the development of metastatic CRC treatments which would directly benefit these patients.
Tumor invasion and metastasis are complex, multistep processes controlled by genetic and epigenetic changes in the tumor. 27 However, the regulatory networks that control such molecular alterations are not clearly understood. As a single miRNA can coordinately suppress multiple target genes and thereby modulate multiple steps of metastatic progression in various cancer types, 28 studies, miR-26b expression is downregulated in sporadic CRC compared with normal colorectal mucosa. 13, 31 On the contrary, it has also been reported that miR-26b expression was upregulated in inflammatory bowel disease-associated carcinogenesis. 12 However, our study 
